Step 2/3

Contrast Media Injectors

Last updated on August 14, 2023
Company Product
Bayer HealthCare Medrad Stellant FLEX CT Injection System
Bayer HealthCare Medrad Stellant Dual CT Injection System w/ Certegra Workstation
Bayer HealthCare Medrad MRXperion MR Injection System
Bayer HealthCare Medrad Mark 7 Arterion Injection System
Bracco SpA EmpowerCTA+ Injector System
Bracco SpA CT Exprès 3D Contrast Media Delivery System
Bracco SpA EmpowerMR Injector System
Guerbet OptiVantage Dual-Head CT Contrast Delivery System with RFID
Guerbet OptiStar Elite MR Contrast Delivery System
Guerbet Illumena Neo Contrast Delivery System
Guerbet OptiOne Single-Head Contrast Delivery System

Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Subscribe Now